Landscapes / Companies
Madrigal Pharmaceuticals
Public MDGL · United States
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
7 active
14 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Thyroid hormone receptor beta (THR-β) agonist |
Approved | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis and 5 more | ||||
| Open drug page | |||||
SEC filings
All on SEC.govNo filings loaded yet.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021